Why the new drug for Alzheimer's disease is causing controversy

Why the new drug for Alzheimer's disease is causing controversy

  • Af
  • Episode
      72
  • Published
      24. jun. 2021
  • Forlag
0 Anmeldelser
0
Episode
72 of 261
Længde
25M
Sprog
Engelsk
Format
Kategori
Personlig udvikling

The U.S. Food and Drug Administration gave "accelerated approval" this month to the first new drug to treat Alzheimer's disease in nearly two decades. But there is controversy over the efficacy of the drug, as well as its cost and side effects. Saska Sivananthan, chief of research and knowledge translation for the Alzheimer Society of Canada, breaks down what we know so far about the drug.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for Why the new drug for Alzheimer's disease is causing controversy

Other podcasts you might like ...